Genetic polymorphisms influencing antihypertensive drug responses
<p dir="ltr">Hypertension is a major contributor to cardiovascular disease and its associated morbidity and mortality. The low efficacy observed with some anti‐hypertensive therapies has been attributed partly to inter‐individual genetic variability. This paper reviews the major find...
محفوظ في:
| المؤلف الرئيسي: | Jana El Cheikh (22330738) (author) |
|---|---|
| مؤلفون آخرون: | Fouad Hamed (22330741) (author), Hana Rifi (22330744) (author), Ali H. Dakroub (22303819) (author), Ali Hussein Eid (13355211) (author) |
| منشور في: |
2024
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Assessing the risk of angiotensin receptor blockers on major cardiovascular events: a systematic review and meta-analysis of randomized controlled trials
حسب: Yara Wanas (8744844)
منشور في: (2020) -
Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs
حسب: Mohamed A. Elrayess (21398687)
منشور في: (2022) -
Revisiting Beta-Blocker Therapy in Heart Failure with Preserved Ejection Fraction
حسب: Rasha Kaddoura (12506936)
منشور في: (2023) -
Successful Use of Intravenous B-blocker Therapy in Cardiogenic Shock Supported With Venoarterial Extracorporeal Membrane Oxygenation: A Case Series
حسب: Alaa Rahhal (14150403)
منشور في: (2022) -
Diagnostic and therapeutic challenges of BRASH syndrome
حسب: Fateen Ata (12217764)
منشور في: (2021)